Research Article

Systemic Associations with Residual Subretinal Fluid after Ranibizumab in Diabetic Macular Edema

Figure 2

Presentation of clinical parameters according to different status of subretinal fluid. (a) Number of eyes with absence of SRF before and after treatment, resolution of initial SRF after treatment, and persistent SRF after treatment. (b) Central macular thickness before and after treatment and (c) HbA1c levels.
(a)
(b)
(c)